Holen Sie sich die Stockscreener-App
7.67
1.72%
0.13
Handel nachbörslich:
7.85
0.18
+2.35%
CorMedix Inc Aktie (CRMD) Neueste Nachrichten
CorMedix (NASDAQ:CRMD) Shares Up 7.3% on Analyst Upgrade - MarketBeat
FY2026 EPS Estimates for CorMedix Raised by HC Wainwright - MarketBeat
(CRMD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
CorMedix Inc (CRMD) Stock News Today - TradingKey
CRMD Stock Jumps As Antifungal Drug Clears Key Trial For $2B Preventive Market - Stocktwits
CorMedix Stock Jumps on Strong DefenCath Sales - Sahm
Full Transcript: Cormedix Q2 2026 Earnings Call - Sahm
CorMedix (NASDAQ:CRMD) Shares Down 4.6%Here's Why - MarketBeat
Royal Bank Of Canada Issues Positive Forecast for CorMedix (NASDAQ:CRMD) Stock Price - MarketBeat
CorMedix's New Major DefenCath Customer Backs 2026 Volumes, Durability Through 2027, RBC Says - marketscreener.com
CRMD Stock Up as Q2 Earnings & Sales Beat on DefenCath, Melinta Gains - The Globe and Mail
RBC Adjusts Price Target on CorMedix to $14 From $13, Maintains Outperform Speculative Risk Rating - Moomoo
CRMD News | CORMEDIX INC (NASDAQ:CRMD) - ChartMill
H.C. Wainwright reiterates CorMedix stock rating on strong quarter - Investing.com
H.C. Wainwright reiterates CorMedix stock rating on strong quarter By Investing.com - Investing.com India
H.C. Wainwright Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $13 - Moomoo
CorMedix (CRMD) Q2 2026 Earnings Call: Revenue Hits $101.9M, EBITDA Guidance Raised - TradingKey
CorMedix Inc (NASDAQ:CRMD) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
CorMedix Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
CorMedix Shares Surge 17% as Q2 Revenue Tops $100 Million, EBITDA Outlook Raised - finance.biggo.com
CorMedix Q2 2026 Earnings Call Transcript - MarketBeat
Needham Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $15 - Moomoo
CorMedix Inc (NASDAQ: CRMD) Share Price, CRMD Stock News, CRMD Share Price & Updates - kalkine.ca
CorMedix Shares Rise After Q2 Results, Guidance - marketscreener.com
CorMedix (NASDAQ:CRMD) Releases Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
CorMedix Q2 revenue hits $101.9M; DEFSEC up 92% YoY - scanx.trade
CorMedix Q2 Earnings Call Highlights - MarketBeat
CorMedix Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CorMedix CEO Expects Supplemental Filing For Fungal Disease Treatment By Q3 – CRMD Stock Sees Best Day In Nearly 10 Months After Earnings Beat - Yahoo Finance
CorMedix earnings beat by $0.06, revenue topped estimates - Investing.com Australia
Earnings call transcript: CorMedix tops Q2 2026 estimates, shares jump 16% - Investing.com Australia
CorMedix (NASDAQ:CRMD) Shares Gap Up Following Earnings Beat - MarketBeat
CorMedix Announces Q2 2026 Revenue Surge to $101.9 Million and Strong Net Income - Kalkine Media
Accelerant Holdings, CorMedix, Birkenstock And Other Big Stocks Moving Higher On Thursday - Benzinga
CRMD: Q2 revenue and EBITDA soared, with new supply deals and pipeline advances driving raised guidance - TradingView
CorMedix Inc. Reiterates Consolidated Earnings Guidance for the Year 2026 - marketscreener.com
Why is CorMedix stock surging today? By Investing.com - Investing.com South Africa
Transcript : CorMedix Inc., Q2 2026 Earnings Call, Aug 13, 2026 - marketscreener.com
CorMedix Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
CRMD: Q2 revenue and EBITDA soared, with new supply deals and pipeline progress driving raised guidance - TradingView
Why is CorMedix stock surging today? - Investing.com
CorMedix Inc. (CRMD) Stock Price, News, Quote & History - Yahoo! Finance Canada
CorMedix (CRMD) Q2 Earnings and Revenues Top Estimates - Yahoo Finance UK
Form 8K CorMedix Inc For: 13 August By Investing.com - Investing.com Australia
CorMedix Inc. (CRMD) revenue jumps as Melinta deal boosts Q2 2026 profit - Stock Titan
CRMD: Q2 2026 revenue and earnings rose sharply, driven by DefenCath and Melinta portfolio growth - TradingView
CorMedix: Q2 Earnings Snapshot - AOL.com
CorMedix reports Q2 2026 consolidated revenue $101.9M, net income $26.0M, adjusted EBITDA $58.7M - TradingView
Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire
CorMedix (CRMD) Earnings Date and Reports 2026 - MarketBeat
CorMedix Inc $CRMD Shares Purchased by Hennion & Walsh Asset Management Inc. - MarketBeat
Cormedix Wins Preliminary OK on Governance Settlement Reforms - The Globe and Mail
Earnings Preview: CorMedix to Report Financial Results Pre-market on August 13 - Moomoo
Form 8K CorMedix Inc For: 7 August By Investing.com - Investing.com South Africa
CorMedix receives preliminary court approval for derivative lawsuit settlement By Investing.com - Investing.com Nigeria
CorMedix receives preliminary court approval for derivative lawsuit settlement - Investing.com
CorMedix secures preliminary court approval for derivative settlement, to adopt governance reforms - TradingView
1.80%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):